Management of erectile dysfunction secondary to treatment for localized prostate cancer.
about
Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivoRace/ethnicity and the receipt of watchful waiting for the initial management of prostate cancerEstimating the risk of long-term erectile, urinary and bowel symptoms resulting from prostate cancer treatment.Sexual function after permanent 125I-brachytherapy for prostate cancer.
P2860
Management of erectile dysfunction secondary to treatment for localized prostate cancer.
description
2001 nî lūn-bûn
@nan
2001 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Management of erectile dysfunction secondary to treatment for localized prostate cancer.
@ast
Management of erectile dysfunction secondary to treatment for localized prostate cancer.
@en
Management of erectile dysfunction secondary to treatment for localized prostate cancer.
@nl
type
label
Management of erectile dysfunction secondary to treatment for localized prostate cancer.
@ast
Management of erectile dysfunction secondary to treatment for localized prostate cancer.
@en
Management of erectile dysfunction secondary to treatment for localized prostate cancer.
@nl
prefLabel
Management of erectile dysfunction secondary to treatment for localized prostate cancer.
@ast
Management of erectile dysfunction secondary to treatment for localized prostate cancer.
@en
Management of erectile dysfunction secondary to treatment for localized prostate cancer.
@nl
P2860
P1433
P1476
Management of erectile dysfunction secondary to treatment for localized prostate cancer.
@en
P2093
P2860
P304
P356
10.1177/107327480100800609
P577
2001-11-01T00:00:00Z